CIP2A and adenocarcinoma: We also find that CIP2A is elevated in 17/19 (89.5%) patients with squamous cell carcinoma, whereas 17/35 (48.6%) patients with adenocarcinoma have over-expressed CIP2A (p = 0.003) (Table 1).